Clinical trials
Mania trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Unknown status | 3 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 2 |
| Ottawa Hospital Research Institute | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Centre Hospitalier St Anne | 1 |
| Dongbin Lyu | 1 |
| Helse Fonna | 1 |
| Max-Planck-Institute of Psychiatry | 1 |
| Mayo Clinic | 1 |
| Mclean Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mania | 23 |
| Bipolar Disorder | 17 |
| Psychotic Disorders | 6 |
| Major Depressive Disorder | 2 |
| Mood Disorders | 2 |
| Schizophrenia | 2 |
| Bipolar and Related Disorders | 1 |
| Cyclothymic Disorder | 1 |
| Disease | 1 |
| Recurrence | 1 |
Trials
Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.